122 patents currently held
121 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2026. from the record
Of the 121 now held by other companies, 79 name Boehringer Ingelheim Animal Health USA Inc. as their current owner, and 42 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
54
Ending by 2030
Dec 2026
Next term end
91
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2037 · High confidence
Also notable
Ends Dec 2031 · High confidence
Also notable
Ends Jul 2031 · High confidence
Process for the Preparation of Isoxazoline Compounds
US 10,433,552
Cited by 12 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2037.
Antiparisitic Dihydroazole Compounds and Compositions Comprising Same
US 8,618,126
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2031.
Parasiticidal Compositions Comprising Multiple Active Agents, Methods and Uses Thereof
US 9,173,403
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2031.
Formerly held, still cited
Notable
Ends Mar 2038 · High confidence
Cited by 8 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2038.
now held by Boehringer Ingelheim Animal Health USA Inc.
Also notable
Ends Apr 2038 · High confidence
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2038.
now held by Boehringer Ingelheim Vetmedica GmbH
Also notable
Ends Jan 2033 · High confidence
Cited by 22 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
now held by Boehringer Ingelheim Animal Health USA Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for HER2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals (US 9,040,053) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 3 fees due Dec 2 to 9, 2026 · next Dec 2
- 2 fees due Feb 18 to 25, 2027 · next Feb 18
- 1 fee due Mar 8, 2027The maintenance fee for Compositions Comprising an Aryl Pyrazole and a Substituted Imidazole, Methods and Uses Thereof (US 9,125,407) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
- 2 fees due Apr 8 to 27, 2027 · next Apr 8
- 3 fees due May 3 to 10, 2027 · next May 3
- 2 fees due Jun 22, 2027
- 1 fee due Jul 5, 2027The maintenance fee for Leishmania Vaccine Using Sand Fly Salivary Immunogen (US 9,228,002) comes due Jul 5, 2027. Unpaid by Jan 5, 2028, it lapses early.
- 1 fee due Aug 2, 2027The maintenance fee for Anthelmintic Compounds and Compositions and Method of Using Thereof (US 9,249,102) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
- 1 fee due Sep 1, 2027The maintenance fee for Processes for the Preparation of 1-ARYL-5-Alkyl Pyrazole Compounds (US 9,273,007) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
- 1 fee due Nov 3, 2027The maintenance fee for Recombinant CDV Compositions and Uses Thereof (US 9,327,137) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
- 3 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 91 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Antiparisitic Dihydroazole Compounds and Compositions Comprising Same | 4 in force | to Dec 2031 |
| Parasiticidal Compositions Comprising Benzimidazole Derivatives, Methods and Uses Thereof | 3 in force | to Apr 2033 |
| 1-ARYL-5-Alkyl Pyrazole Derivative Compounds, Processes of Making and Methods of Using Thereof | 3 in force | to Aug 2028 |
| Parasiticidal Compositions Comprising Indole Derivatives, Methods and Uses Thereof | 2 in force | to Jun 2035 |
| Anthelmintic Compounds and Compositions and Method of Using Thereof | 2 in force | to Nov 2033 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,671,034 | Stabilized Formulation of Ivermectin Feed Premix with an Extended Shelf Life In force · High confidence | In force | High confidence | |
| US 7,659,288 | 5-Aminoalkylpyrazole Derivatives as Pesticidal Agents In force · High confidence | In force | High confidence | |
| US 8,420,389 | Nipah Virus Vaccines In force · High confidence | In force | High confidence | |
| US 7,829,323 | Mixing Devices for Chemical Lysis of Cells In force · High confidence | In force | High confidence | |
| US 7,834,003 | 5-Aminopyrazole Derivatives as Pesticidal Compounds In force · High confidence | In force | High confidence | |
| US 7,455,844 | Vaccine Against Streptococci In force · High confidence | In force | High confidence | |
| US 7,700,639 | Chemical Compounds, Process for Their Preparation and Use Thereof In force · High confidence | In force | High confidence | |
| US 8,916,592 | Malononitrile Compounds In force · High confidence | In force | High confidence | |
| US 9,169,042 | Energy Absorbing Container In force · Medium confidence | In force | Medium confidence | |
| US 7,820,709 | N-Phenylpyrazole Derivatives as Pesticides In force · High confidence | In force | High confidence |
Also on record, not counted in the 122: 121 patents in force now held by others · 89 patents ended · 5 applications pending · 46 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.